Teleflex Stock Crosses 200-Day Moving Average

Shares of the medical technology company hit a new high, but what's next for investors?

Apr. 11, 2026 at 3:18am

Got story updates? Submit your updates here. ›

A cinematic close-up of intricately detailed banking and financial machinery, conveying the idea of the complex, institutional forces driving stock market activity without using literal currency or charts.An extreme close-up of the heavy, industrial machinery that powers the financial markets, hinting at the complex systems and institutional forces behind Teleflex's stock price movement.Wayne Today

Teleflex Incorporated (NYSE:TFX), a diversified global provider of medical technologies, saw its stock price cross above its 200-day moving average during trading on Wednesday. The stock reached as high as $119.62 before closing at $119.19 with over 690,000 shares traded.

Why it matters

Crossing above the 200-day moving average is often seen as a bullish technical indicator, suggesting the stock may be entering a new upward trend. However, analysts have mixed views on Teleflex's near-term prospects, with some maintaining a 'sell' rating while others see further upside potential.

The details

Teleflex's stock has been on a volatile ride over the past year, impacted by the COVID-19 pandemic's effect on healthcare procedures and supply chains. The company reported weaker-than-expected earnings in its most recent quarter, missing analyst estimates. However, Teleflex has also received positive ratings from some research firms who see the company's diversified product portfolio and focus on critical care and surgical devices as long-term growth drivers.

  • Teleflex's stock price crossed above its 200-day moving average of $116.10 on Wednesday, April 11, 2026.
  • In its most recent earnings report on February 26, 2026, Teleflex posted earnings per share of $1.93, missing analyst estimates of $3.73.

The players

Teleflex Incorporated

A diversified global provider of medical technologies, specializing in critical care and surgery. The company designs, manufactures and distributes devices and solutions used by healthcare professionals.

Weiss Ratings

A research firm that has maintained a 'sell' rating on Teleflex shares.

Needham & Company LLC

An investment bank that has a 'buy' rating on Teleflex and increased its price target for the stock.

Wells Fargo & Company

A financial services firm that has an 'equal weight' rating on Teleflex and increased its price target for the stock.

Wall Street Zen

A research firm that downgraded Teleflex from a 'hold' rating to a 'sell' rating.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

What’s next

Investors will be closely watching Teleflex's upcoming earnings report and any further updates on the company's performance and outlook.

The takeaway

Teleflex's stock price movement highlights the volatility and uncertainty facing the medical technology sector, as the company navigates the ongoing impact of the pandemic while also seeking to capitalize on long-term growth opportunities in critical care and surgical devices.